Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Baruchel

Showing results (251-260 of 590) with videos related to

Pageof 59
Sort By:
Human Immunology|July 24, 2012
Cellular and humoral immunity elicited by influenza vaccines in pediatric hematopoietic-stem cell transplantationValérie Guérin-El Khourouj, Marie Duchamp, Anne Krivine, et al.
The Lancet. Oncology|November 27, 2013
Neonatal cancerDaniel Orbach, Sabine Sarnacki, Hervé J Brisse, et al.
Leukemia Research|December 29, 2020
Synergy of FLT3 inhibitors and the small molecule inhibitor of LIM kinase1/2 CEL_Amide in FLT3-ITD mutated Acute Myeloblastic Leukemia (AML) cellsHanane Djamai, Jeannig Berrou, Mélanie Dupont, et al.
Cancer Causes & Control : CCC|January 26, 2002
Family cancer history and risk of childhood acute leukemia (France)F Perrillat, J Clavel, I Jaussent, et al.
British Journal of Haematology|May 20, 2020
Inotuzumab ozogamicin compassionate use for French paediatric patients with relapsed or refractory CD22-positive B-cell acute lymphoblastic leukaemiaCharlotte Calvo, Aurélie Cabannes-Hamy, Dalila Adjaoud, et al.
The New England Journal of Medicine|October 17, 1991
Sickle cell disease in a patient with sickle cell trait and compound heterozygosity for hemoglobin S and hemoglobin Quebec-ChoriH E Witkowska, B H Lubin, Y Beuzard, et al.
Ejhaem|March 9, 2026
Selumetinib as an Effective Therapy of Histiocytic Sarcoma Evolving From a B-Cell Acute Lymphoblastic LeukaemiaLaetitia Largeaud, Charlotte Syrykh, Julie Vial, et al.
Translational Oncology|May 27, 2018
Hypoxia-Targeting Drug Evofosfamide (TH-302) Enhances Sunitinib Activity in Neuroblastoma Xenograft ModelsSushil Kumar, Jessica D Sun, Libo Zhang, et al.
Journal of Pediatric Hematology/Oncology|May 17, 2019
MYCN Amplified Relapse Following Resolution of MYCN Nonamplified 4S Neuroblastoma With Placental Involvement: A Case Report and Review of the LiteratureKarin P S Langenberg-Ververgaert, Samuele Renzi, Catherine T Chung, et al.
Human Mutation|June 30, 2000
The spectrum of mutations, including four novel ones, in the thiamine-responsive megaloblastic anemia gene SLC19A2 of eight familiesT Raz, V Labay, D Baron, et al.
Pageof 59

Showing results (251-260 of 590) with videos related to

Sort By:
Pageof 59
Human Immunology|July 24, 2012
Cellular and humoral immunity elicited by influenza vaccines in pediatric hematopoietic-stem cell transplantationValérie Guérin-El Khourouj, Marie Duchamp, Anne Krivine, et al.
The Lancet. Oncology|November 27, 2013
Neonatal cancerDaniel Orbach, Sabine Sarnacki, Hervé J Brisse, et al.
Leukemia Research|December 29, 2020
Synergy of FLT3 inhibitors and the small molecule inhibitor of LIM kinase1/2 CEL_Amide in FLT3-ITD mutated Acute Myeloblastic Leukemia (AML) cellsHanane Djamai, Jeannig Berrou, Mélanie Dupont, et al.
Cancer Causes & Control : CCC|January 26, 2002
Family cancer history and risk of childhood acute leukemia (France)F Perrillat, J Clavel, I Jaussent, et al.
British Journal of Haematology|May 20, 2020
Inotuzumab ozogamicin compassionate use for French paediatric patients with relapsed or refractory CD22-positive B-cell acute lymphoblastic leukaemiaCharlotte Calvo, Aurélie Cabannes-Hamy, Dalila Adjaoud, et al.
The New England Journal of Medicine|October 17, 1991
Sickle cell disease in a patient with sickle cell trait and compound heterozygosity for hemoglobin S and hemoglobin Quebec-ChoriH E Witkowska, B H Lubin, Y Beuzard, et al.
Ejhaem|March 9, 2026
Selumetinib as an Effective Therapy of Histiocytic Sarcoma Evolving From a B-Cell Acute Lymphoblastic LeukaemiaLaetitia Largeaud, Charlotte Syrykh, Julie Vial, et al.
Translational Oncology|May 27, 2018
Hypoxia-Targeting Drug Evofosfamide (TH-302) Enhances Sunitinib Activity in Neuroblastoma Xenograft ModelsSushil Kumar, Jessica D Sun, Libo Zhang, et al.
Journal of Pediatric Hematology/Oncology|May 17, 2019
MYCN Amplified Relapse Following Resolution of MYCN Nonamplified 4S Neuroblastoma With Placental Involvement: A Case Report and Review of the LiteratureKarin P S Langenberg-Ververgaert, Samuele Renzi, Catherine T Chung, et al.
Human Mutation|June 30, 2000
The spectrum of mutations, including four novel ones, in the thiamine-responsive megaloblastic anemia gene SLC19A2 of eight familiesT Raz, V Labay, D Baron, et al.
Pageof 59